Hologic (HOLX)
(Delayed Data from NSDQ)
$78.76 USD
-0.53 (-0.67%)
Updated Nov 8, 2024 03:59 PM ET
After-Market: $78.78 +0.02 (0.03%) 7:02 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.76 USD
-0.53 (-0.67%)
Updated Nov 8, 2024 03:59 PM ET
After-Market: $78.78 +0.02 (0.03%) 7:02 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Zacks News
Is a Surprise in Store for Hologic (HOLX) in Q1 Earnings?
by Zacks Equity Research
Hologic Inc. (HOLX) is slated to report first-quarter fiscal 2017 financial results on Feb 1, after the closing bell.
The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic
3 Medical Device Stocks Likely to Beat Earnings Estimates
by Zacks Equity Research
The likely revocation of the 2.3% medical device excise tax is going to be a big bonus for both the behemoths and small players.
Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay
by Zacks Equity Research
Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay.
Hologic (HOLX) to Divest Blood Screening Business to Grifols
by Zacks Equity Research
Hologic, Inc. (HOLX) recently inked a deal to divest its stake in the blood screening business.
Hologic Hits 52-Week High on Q4 Earnings & Solid Prospects
by Zacks Equity Research
Share price of Bedford, MA-based Hologic Inc. (HOLX) reached a new 52-week high of $41.01 on Dec 14, finally closing a tad lower at $40.79.
Whole Foods (WFM) Will No Longer be Part of Nasdaq-100
by Zacks Equity Research
As a result of the annual re-ranking of the NASDAQ-100 index, Whole Foods (WFM) will cease to be a part of the same.
Bed Bath and Beyond (BBBY) Loses its Place in Nasdaq-100
by Zacks Equity Research
The NASDAQ-100 Index as part of its annual re-ranking process has decided to remove Bed, Bath & Beyond Inc. (BBBY).
4 Medical Instrument Stocks to Bet on This Earnings Season
by Zacks Equity Research
The medical instrument sector holds a lot of promise at this moment.
Top 3 MedTech Stocks Poised to Gain this Earnings Season
by Zacks Equity Research
A bipartisan group of ten senators signed on a bill to repeal the 2.3% federal excise tax on medical device makers.